title: End-of-life cancer care in Ontario and the United States: quality by accident or quality by design?
authors.forename: David
authors.initials: D
authors.lastname: Goodman
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002170:Canada / Q000453:epidemiology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000628:therapy*; D003657:Decision Making; D017051:Hospice Care / Q000639:trends; D006760:Hospitalization; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000628:therapy*; D009864:Ontario / Q000453:epidemiology; D010166:Palliative Care / Q000592:standards / Q000639:trends; D010358:Patient Participation; D011787:Quality of Health Care; D013727:Terminal Care / Q000592:standards / Q000639:trends; D014481:United States / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents